Citation 2638

GANZERA,M: SCHNEIDER,P: STUPPNER,H:. (2006). INHIBITORY EFFECTS OF THE ESSENTIAL OIL OF CHAMOMILE (MATRICARIA RECUTITA L.) AND ITS MAJOR CONSTITUENTS ON HUMAN CYTOCHROME P450 ENZYMES. 78(8)

Citation Details

Title	INHIBITORY EFFECTS OF THE ESSENTIAL OIL OF CHAMOMILE (MATRICARIA RECUTITA L.) AND ITS MAJOR CONSTITUENTS ON HUMAN CYTOCHROME P450 ENZYMES
Authors	GANZERA,M: SCHNEIDER,P: STUPPNER,H:
Year	2006
Volume	78
Issue	8

Summary

Year: 2006

Journal: Unknown

Organisms and Their Experiments (1)

Matricaria chamomilla (ASTERACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	CYTOCHROME P450 INHIBITION	PHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
2	CYTOCHROME P450 INHIBITION	PHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
3	CYTOCHROME P450 INHIBITION	PHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
4	CYTOCHROME P450 INHIBITION	PHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
5	Not specified	IDENTIFICATION IN BY HPLC	BISABOLOL, ALPHA:	None
6	CYTOCHROME P450 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BISABOLOL, ALPHA:	INACTIVE
7	CYTOCHROME P450 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BISABOLOL, ALPHA:	ACTIVE
8	CYTOCHROME P450 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BISABOLOL, ALPHA:	ACTIVE
9	CYTOCHROME P450 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BISABOLOL, ALPHA:	ACTIVE
10	Not specified	IDENTIFICATION IN BY HPLC	BISABOLOL OXIDE A	None
11	CYTOCHROME P450 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BISABOLOL OXIDE ABISABOLOL OXIDE B	INACTIVE
12	CYTOCHROME P450 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BISABOLOL OXIDE ABISABOLOL OXIDE B	WEAK ACTIVITY
13	CYTOCHROME P450 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BISABOLOL OXIDE ABISABOLOL OXIDE B	WEAK ACTIVITY
14	CYTOCHROME P450 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BISABOLOL OXIDE ABISABOLOL OXIDE B	ACTIVE
15	Not specified	IDENTIFICATION IN BY HPLC	BISABOLOL OXIDE B	None
16	Not specified	IDENTIFICATION IN BY HPLC	CHAMAZULENE	None
17	CYTOCHROME P450 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHAMAZULENE	ACTIVE
18	CYTOCHROME P450 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHAMAZULENE	WEAK ACTIVITY
19	CYTOCHROME P450 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHAMAZULENE	ACTIVE
20	CYTOCHROME P450 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FARNESENE	ACTIVE
21	Not specified	IDENTIFICATION IN BY HPLC	FARNESENE	None
22	CYTOCHROME P450 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FARNESENE	INACTIVE
23	CYTOCHROME P450 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FARNESENE	WEAK ACTIVITY
24	CYTOCHROME P450 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FARNESENE	ACTIVE
25	CYTOCHROME P450 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ENYNE BICYCLO ETHER,CIS:	ACTIVE
26	Not specified	IDENTIFICATION IN BY HPLC	ENYNE BICYCLO ETHER,CIS:	None
27	CYTOCHROME P450 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ENYNE BICYCLO ETHER,CIS:	ACTIVE
28	CYTOCHROME P450 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ENYNE BICYCLO ETHER,CIS:	INACTIVE
29	CYTOCHROME P450 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ENYNE BICYCLO ETHER,CIS:	WEAK ACTIVITY
30	CYTOCHROME P450 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ENYNE BICYCLO ETHER,TRANS:	ACTIVE
31	Not specified	IDENTIFICATION IN BY HPLC	ENYNE BICYCLO ETHER,TRANS:	None
32	CYTOCHROME P450 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ENYNE BICYCLO ETHER,TRANS:	STRONG ACTIVITY
33	CYTOCHROME P450 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ENYNE BICYCLO ETHER,TRANS:	INACTIVE
34	CYTOCHROME P450 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ENYNE BICYCLO ETHER,TRANS:	ACTIVE
35	CYTOCHROME P450 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ENYNE BICYCLO ETHER,TRANS:	ACTIVE

Citation 2638

Citation Details

Summary

Organisms and Their Experiments (1)

Matricaria chamomilla (ASTERACEAE)

Show SPARQL Queries (1)

Query 1